EUVIMEDEUVIMED entdecken
Multizentrische Studie

Treatment Outcomes of Endoscopic Lung Volume Reduction with Valves in Advanced Lung Emphysema Patients Are Largely Independent of Body Mass Index: Data from the German Lung Emphysema Registry

Jacopo Saccomanno, Thomas Sgarbossa, Konrad Neumann, Kaid Darwiche, Stefan Andreas, Stephan Eisenmann, Bernd Schmidt, Wolfgang Gesierich, Nicolas Dickgreber, Christian Geltner, Joachim H Ficker, Angelique Holland und 13 weitere

Respiration · 17.11.2026 · 105 (10) · 1117-1129

DOI: 10.1159/000551036 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respiration, online erschienen am 03.03.2026. Verfasst von Jacopo Saccomanno und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humbold…. Hauptthemen laut MEDLINE: Pulmonary Emphysema, Body Mass Index, Pneumonectomy, Bronchoscopy. Die Arbeit nennt 37 Literaturangaben. Gefördert von: CAPNETZ STIFTUNG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Endoscopic lung volume reduction (ELVR) via valves is a proven therapeutic option for patients with advanced chronic obstructive pulmonary disease (COPD) and emphysema without collateral ventilation. Body mass index (BMI), a simple measure of adiposity, has a complex relationship with COPD. A lower BMI is associated with increased mortality in this patient population. However, the influence of BMI on the outcome of ELVR remains unclear.

Methods

This analysis was conducted with data from the Lung Emphysema Registry (www.lungenemphysemregister.de), a national, prospective, multicentric, producer-independent, open-label clinical trial. The aim of this study was to evaluate the impact of baseline BMI on treatment outcomes after ELVR. Patients were grouped according to their BMI as follows: underweight (BMI <20 kg/m2, n = 76), normal weight (20–24.9 kg/m2, n = 282), overweight (BMI = 25–30 kg/m2, n = 146), and obese (BMI >30 kg/m2, n = 45).

Results

Baseline parameters were characteristic of patients with advanced lung emphysema. Emphysema scores and heterogeneity indices of the target lobe were greater in patients with lower BMI. Patients with a lower BMI had worse lung function parameters (FEV1, RV, DLCO, pCO2) and a higher CAT score. All groups showed significant improvements after ELVR at the 3-month follow-up in terms of lung function parameters, exercise capacity, and quality of life. Treatment outcomes were comparable across BMI groups, with the notable exception of more pronounced improvement in CAT scores among underweight patients. The complication rates were low and comparable among the groups, although obese patients had a higher rate of ICU admissions.

Conclusion

This study suggests that ELVR provides meaningful clinical benefits regardless of BMI in patients with advanced lung emphysema, particularly when dyspnea is primarily attributable to pulmonary pathology. The findings suggest that BMI should be considered as a reflection of disease phenotype and clinical state rather than serving as a predictor for treatment response after ELVR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmphysemaBody Mass IndexPneumonectomyBronchoscopyEndoscopyHumansFemaleMaleRegistriesAgedTreatment OutcomeMiddle AgedGermanyProspective StudiesObesity

Stichwörter der Autor:innen

Body mass indexChronic obstructive pulmonary diseaseEndoscopic lung volume reductionInterventional pneumologyLung emphysema

Autor:innen und Institutionen

  • Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Department of Pulmonology, Lungenklinik Hemer, Hemer, Germany.
  • Center for Respiratory Medicine, Lungenfachklinik Immenhausen, Immenhausen, Germany.
  • German Center for Lung Research (DZL), Berlin, Germany.
  • Department of Respiratory Medicine, Universitätsklinikum Halle, Halle, Germany.

Förderung

  • CAPNETZ STIFTUNG

Zitieren

APA

Saccomanno, J., Sgarbossa, T., Neumann, K., Darwiche, K., Andreas, S., Eisenmann, S., Schmidt, B., Gesierich, W., Dickgreber, N., Geltner, C., Ficker, J. H., Holland, A., Schwick, B., Eggeling, S., Eberhardt, R., Grah, C., Hünermann, C., Sommerwerck, U., Fertl, A., …, & Hübner, R. H. (2026). Treatment Outcomes of Endoscopic Lung Volume Reduction with Valves in Advanced Lung Emphysema Patients Are Largely Independent of Body Mass Index: Data from the German Lung Emphysema Registry. Respiration, 105(10), 1117-1129. https://doi.org/10.1159/000551036

Vancouver

Saccomanno J, Sgarbossa T, Neumann K, Darwiche K, Andreas S, Eisenmann S, et al. Treatment Outcomes of Endoscopic Lung Volume Reduction with Valves in Advanced Lung Emphysema Patients Are Largely Independent of Body Mass Index: Data from the German Lung Emphysema Registry. Respiration. 2026;105(10):1117-1129. doi:10.1159/000551036

BibTeX
@article{Saccomanno2026,
  author = {Saccomanno, Jacopo and Sgarbossa, Thomas and Neumann, Konrad and Darwiche, Kaid and Andreas, Stefan and Eisenmann, Stephan and Schmidt, Bernd and Gesierich, Wolfgang and Dickgreber, Nicolas and Geltner, Christian and Ficker, Joachim H and Holland, Angelique and Schwick, Björn and Eggeling, Stephan and Eberhardt, Ralf and Grah, Christian and Hünermann, Christoph and Sommerwerck, Urte and Fertl, Andreas and Kurz, Sylke and Schramm, Peter and Krist, Joanna and Barten-Neiner, Grit and Witzenrath, Martin and Hübner, Ralf-Harto},
  title = {Treatment Outcomes of Endoscopic Lung Volume Reduction with Valves in Advanced Lung Emphysema Patients Are Largely Independent of Body Mass Index: Data from the German Lung Emphysema Registry},
  journal = {Respiration},
  year = {2026},
  volume = {105},
  number = {10},
  pages = {1117--1129},
  doi = {10.1159/000551036}
}
Kostenlos starten →